Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, today announced the appointment of ...

Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report first-quarter fiscal 2026 results on Feb. 9, ...

He joins a company that on Jan. 26 announced Michael Iskra as its new CEO, succeeding Arnon Chait, who has held the title since he co-founded the company in 2013. Chait now has the title of chief ...

The conversion of large-scale, complex mass spectrometry data into meaningful structural insights through ChemEcho, a machine learning embedding method, published in August by investigators at ...

Becton, Dickinson and Company (NYSE:BDX) shareholders approved all four proposals presented at the company’s annual meeting, ...

Health financing models determine whether services are covered or paid out-of-pocket. Workforce policies affect retention and ...

Becton Dickinson (NYSE:BDX) is spinning off its Biosciences & Diagnostic Solutions business, which will combine with Waters Corporation after shareholder and regulatory approvals. The transaction will ...

BD and Envetec prove medical plastic waste can be safely recycled into new products reducing landfill dependency ...

We came across a bullish thesis on Becton, Dickinson and Company on Value Don’t Lie’s Substack. In this article, we will ...

BD (Becton, Dickinson and Company) recently participated as Knowledge Partner at the World Regional Anaesthesia & Pain ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...